Agilent Recognized by Forbes as One of America’s Best Employers for Diversity SANTA CLARA, Calif., January 16, 2019 Agilent Technologies Inc. (NYSE: A) today announced that it has been recognized by Forbes as one of America’s Best Employers for Diversity 2019. Agilent is ranked number 53 of the 500 companies on the list. “We’re proud... Read more
Agilent Receives 2018 Innovation Award from The Analytical Scientist New spectroscopy system represents a breakthrough in chemical imaging and spectral analysis SANTA CLARA, Calif., December 20, 2018 Agilent Technologies Inc. (NYSE: A) today announced that the latest addition to its infrared spectroscopy portfolio has been recognized as one of 2018’s best analytical advances. The Analytical... Read more
Agilent Technologies to Present at Goldman Sachs Healthcare CEO Conference and JP Morgan Healthcare Conference SANTA CLARA, Calif., December 19, 2018 Agilent Technologies Inc. (NYSE: A) today announced the following webcasts for the investment community: 11th Annual Goldman Sachs Healthcare CEO Conference New York CityThursday, January 3, 20199:30am – 10:10am ETMike McMullen, Agilent president and chief... Read more
Agilent Expands Cell Analysis R&D Capabilities in Ireland New facility incorporates recently acquired Luxcel Biosciences SANTA CLARA, Calif., November 16, 2018 Agilent Technologies Inc. (NYSE: A) today announced the opening of a new, purpose-built extension to its Little Island, Cork facility in Ireland. The campus will focus on developing advanced technologies for the analysis of... Read more
Agilent Completes Acquisition of ACEA Biosciences Acquisition Brings Together Two Pioneers in Cellular Function and Metabolism Measurements SANTA CLARA, Calif., November 14, 2018 Agilent Technologies Inc. (NYSE: A) today announced it has completed the acquisition of ACEA Biosciences Inc. (ACEA), a developer of cutting-edge cell analysis tools, for $250 million in cash. This acquisition brings together... Read more
Agilent Technologies to Present at Evercore ISI HealthCONx SANTA CLARA, Calif., November 12, 2018 Agilent Technologies Inc. (NYSE: A) today announced the following webcast for the investment community: Evercore ISI HealthCONxBoston Harbor Hotel, Boston, MassachusettsTuesday, November 27, 2018 at 2:00 p.m. ETMike McMullen, Agilent president and chief executive offic Links to the webcasts will be... Read more
Agilent Introduces New ICP-MS Water Analyzer Solution Fully integrated solution increases productivity of environmental labs SANTA CLARA, Calif., November 2, 2018 Agilent Technologies Inc. (NYSE: A) today introduced a new turnkey solution for analyzing water quality. The Agilent ICP-MS Water Analyzer enables environmental laboratories to set up and run regulated methods in a matter of... Read more
Agilent Introduces Groundbreaking UV-Vis Spectrophotometer for Pharmaceutical, Biomedical, and Academic Laboratories Cary 3500 UV-Vis system can run multiple experiments simultaneously, boosting laboratory efficiency SANTA CLARA, Calif., November 1, 2018 Agilent Technologies Inc. (NYSE: A) today introduced the Cary 3500 UV-Vis system, an innovative spectrophotometer designed to help life science, pharma and biopharma research communities simplify... Read more
Agilent Introduces Unique Next Generation Sequencing-based Preimplantation Genetic Testing (PGT) Solution Agilent OnePGT solution empowers fertility specialists to attain comprehensive insights to improve the ranking of in vitro fertilized (IVF) embryos SANTA CLARA, Calif., October 31, 2018 Agilent Technologies Inc. (NYSE: A) today announced the introduction of Agilent OnePGT, a genome-wide, next-generation sequencing (NGS) solution... Read more
Agilent Sends Letter to the SEC Regarding Material Misstatements in Twist Bioscience’s S-1 Registration Statement SANTA CLARA, Calif., October 29, 2018 Agilent Technologies Inc. (NYSE: A) today announced that it sent a letter to the Division of Corporation Finance of the U.S. Securities and Exchange Commission (SEC) regarding misstatements in the S-1 Registration Statement filed... Read more